Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - PA: Eileen Iwanicki Fellowships in Breast Cancer Research

Direct Payment

$75,000.00

Targeting quiescent cancer cells

FY 2015-16

Summary
One of the biggest challenges in cancer is the recurrence of the disease after years of cancer-free living. Scientists now think that a reason for this is that sometimes a small number of cancer cells originating from the primary tumor disperse throughout the body and remain in a state of dormancy called quiescence (G0). G0 cells are non-dividing, long-lived cells which retain their ability to rapidly grow and form tumors years after the initial treatment. Most problematically, these G0 tumor cells are resistant to conventional drugs and treatments. Currently, there are no drugs for killing or neutralizing G0 cells. In an effort to target these cells, I plan to identify and understand the key pathways cells use to transition from proliferation to quiescence. When cells transition into G0, they alter the physical structure of their chromosomes which we think allows cells to regulate the expression of their genes, optimizing their survivability in dormancy. I will use a model organism, fission yeast, which easily and reversibly can be manipulated to enter G0 with 100% efficiency. This is much quicker than using human cancer cell lines in which pure populations of G0 cells are difficult to obtain. Most of the key proteins that maintain proper chromosome structure are well conserved from yeast to human cells, thus making the fission yeast an excellent model for studying quiescence. Using this model, already the Motamedi lab has identified several proteins that are required for survival of G0 cells. Next, I plan to determine whether the same proteins also are essential for human breast cancer cells to survive in quiescence and to test whether targeting these proteins by drugs can kill these dormant cancer cells. Overall, understanding how cells survive in quiescence will yield insight into the mechanism of tumor dormancy and may lead to the development of new drugs against quiescent cancer cells - badly needed drugs for fighting cancer.
Program
Fellowship - PA: Eileen Iwanicki Fellowships in Breast Cancer Research
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
340035
Name
ShojaeiSaadi HabibAllah
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Partnername
Breast Cancer Society of Canada (North Sarnia, ON)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Targeting quiescent cancer cells
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Fellowship - PA: Eileen Iwanicki Fellowships in Breast Cancer Research
Keyworddelim
Anti-Tumor Drug; Breast Cancer; Cancer Biology; Cancer Cell Culture; Chip-Seq; Epigenetics; Non-Coding Rnas; Quiescent Tumor Cells; Rna-Seq; Transcriptomics
Abstract
One of the biggest challenges in cancer is the recurrence of the disease after years of cancer-free living. Scientists now think that a reason for this is that sometimes a small number of cancer cells originating from the primary tumor disperse throughout the body and remain in a state of dormancy called quiescence (G0). G0 cells are non-dividing, long-lived cells which retain their ability to rapidly grow and form tumors years after the initial treatment. Most problematically, these G0 tumor cells are resistant to conventional drugs and treatments. Currently, there are no drugs for killing or neutralizing G0 cells. In an effort to target these cells, I plan to identify and understand the key pathways cells use to transition from proliferation to quiescence. When cells transition into G0, they alter the physical structure of their chromosomes which we think allows cells to regulate the expression of their genes, optimizing their survivability in dormancy. I will use a model organism, fission yeast, which easily and reversibly can be manipulated to enter G0 with 100% efficiency. This is much quicker than using human cancer cell lines in which pure populations of G0 cells are difficult to obtain. Most of the key proteins that maintain proper chromosome structure are well conserved from yeast to human cells, thus making the fission yeast an excellent model for studying quiescence. Using this model, already the Motamedi lab has identified several proteins that are required for survival of G0 cells. Next, I plan to determine whether the same proteins also are essential for human breast cancer cells to survive in quiescence and to test whether targeting these proteins by drugs can kill these dormant cancer cells. Overall, understanding how cells survive in quiescence will yield insight into the mechanism of tumor dormancy and may lead to the development of new drugs against quiescent cancer cells - badly needed drugs for fighting cancer.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
ShojaeiSaadi, HabibAllah
Approvedterm
3 ans 0 mois
Cihrcontribution2
Breast Cancer Initiative~ $75,000~ $0~
Direct Payment - $75,000 Grant (2015-16) | Canada Spends